R. Morandini et al., ACTION OF CAMP ON EXPRESSION AND RELEASE OF ADHESION MOLECULES IN HUMAN ENDOTHELIAL-CELLS, American journal of physiology. Heart and circulatory physiology, 39(3), 1996, pp. 807-816
The expression of E-selectin induced by tumor necrosis factor (TNF) on
the surface of human umbilical vein endothelial cells (HUVEC) was par
tially inhibited by an increase in the level of adenosine 3',5'-cyclic
monophosphate (cAMP), produced by forskolin or cholera toxin combined
with the type IV phosphodiesterase inhibitor rolipram and the protein
kinase A agonist phosphorothioate analogue of cAMP SpcAMPS. The same
agents had no significant effect on the constitutive and TNF-stimulate
d expression of intercellular adhesion molecule 1 (ICAM-1), whereas th
e effect on vascular cell adhesion molecule 1 (VCAM-1) expression was
variable depending on cell culture conditions. The stimulatory effects
of phorbol 12-myristate 13-acetate and bacterial lipopolysaccharide (
LPS) on E-selectin expression were also downregulated by the forskolin
-rolipram combination and by SpcAMPS. Inhibition of the surface expres
sion of E-selectin was associated with a decrease of the total amount
of the protein in the cell lysate and a reduced mRNA level, with no si
gnificant effect on mRNA stability. In anesthetized rats, the terbutal
ine-rolipram combination reduced the rolling of leukocytes induced by
LPS in the mesenteric microcirculation. In addition to their partial i
nhibitory effect on the TNF-induced surface expression of E-selectin o
n HUVEC, the forskolin-rolipram combination and SpcAMPS strongly inhib
ited the release of soluble E-selectin from these cells; the release o
f soluble ICAM-1 and VCAM-1 was unaffected by these agents. Isoprotere
nol reduced the release of soluble E-selectin, whereas it had no signi
ficant effect on the cell surface expression of the protein. This stud
y underscores the potential anti-inflammatory effect of a rise in the
endothelial cAMP level.